CW Advisors LLC Takes $764,000 Position in Waters Corporation $WAT

Key Points

• CW Advisors LLC acquired a new position in Waters Corporation worth approximately $764,000 by purchasing 2,070 shares in the first quarter.
• Waters reported $2.95 EPS for the last quarter, surpassing estimates by $0.02, and had revenues of $771.33 million, an increase of 8.8% from the previous year.
• An analyst consensus rating for Waters is "Hold" with an average target price of $378.73, while several brokerages have adjusted their price objectives recently.

CW Advisors LLC bought a new stake in shares of Waters Corporation (NYSE:WAT - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,070 shares of the medical instruments supplier's stock, valued at approximately $764,000.

Other hedge funds have also recently modified their holdings of the company. Olde Wealth Management LLC bought a new position in shares of Waters during the first quarter valued at approximately $25,000. Zions Bancorporation National Association UT bought a new position in Waters in the first quarter worth approximately $28,000. IFP Advisors Inc grew its stake in Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after purchasing an additional 44 shares in the last quarter. Whipplewood Advisors LLC grew its stake in Waters by 5,200.0% in the first quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock worth $39,000 after purchasing an additional 104 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd bought a new position in Waters in the first quarter worth approximately $41,000. Institutional investors own 94.01% of the company's stock.

Waters Stock Performance

Shares of WAT opened at $296.72 on Wednesday. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The stock has a fifty day moving average price of $312.40 and a 200-day moving average price of $340.51. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. The firm has a market cap of $17.66 billion, a PE ratio of 26.76, a P/E/G ratio of 2.79 and a beta of 1.04.

Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, beating the consensus estimate of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $771.33 million during the quarter, compared to analyst estimates of $745.96 million. During the same quarter in the prior year, the business posted $2.63 EPS. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Equities research analysts predict that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently issued reports on WAT. Wells Fargo & Company dropped their price objective on Waters from $330.00 to $315.00 and set an "equal weight" rating on the stock in a research note on Tuesday, August 5th. Robert W. Baird dropped their price objective on Waters from $374.00 to $352.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 16th. Jefferies Financial Group set a $385.00 price objective on Waters and gave the stock a "buy" rating in a research note on Monday, August 4th. Bank of America increased their price objective on Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Finally, Scotiabank reissued a "sector outperform" rating and issued a $465.00 price objective on shares of Waters in a research note on Friday, July 11th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $378.73.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.